SCHEMBL8675612

SCHEMBL8675612

O=P(O)(O)C(CN1CCCCC1)P(=O)(O)O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ANPEP P15144 2/20 0.64
ERAP2 Q6P179 1/20 0.64
MAPT P10636 4/20 0.52
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
FDPS P14324 4/20 0.46
HSD17B10 Q99714 1/20 0.42
ATM Q13315 2/20 0.41
CA12 O43570 2/20 0.40
CA1 P00915 2/20 0.40
CA2 P00918 2/20 0.40
CA9 Q16790 2/20 0.40
ALDH1A1 P00352 2/20 0.39
HPGD P15428 1/20 0.39
MMP1 P03956 1/20 0.37
MMP2 P08253 1/20 0.37
MMP3 P08254 1/20 0.37
MMP9 P14780 1/20 0.37
GAA P10253 1/20 0.35
POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8991677 1.00 ANPEP (0.64) ANPEPERAP2MAPTMEN1KMT2A
SCHEMBL8597910 0.98 ANPEP (0.61) ANPEPERAP2MAPTMEN1KMT2A
SCHEMBL8671774 0.90 ANPEP (0.53) ANPEPERAP2MAPTMEN1KMT2A
SCHEMBL10714751 0.78 FDPS (0.50) ANPEPERAP2MAPTFDPSGAA
SCHEMBL9081590 0.78 ANPEP (0.50) ANPEPERAP2MAPTMEN1KMT2A
SCHEMBL8671777 0.77 ANPEP (0.45) ANPEPERAP2MAPTMEN1KMT2A
SCHEMBL3739664 0.76 ANPEP (0.47) ANPEPERAP2MAPTFDPSCA12
SCHEMBL8672081 0.75 MEN1 (0.41) ANPEPERAP2MAPTMEN1KMT2A
SCHEMBL8528864 0.74 ANPEP (0.55) ANPEPERAP2MAPTMEN1KMT2A
SCHEMBL8672135 0.74 KDM4E (0.55) ANPEPERAP2MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0608322-B1 ENHANCED SKIN PENETRATION SYSTEM FOR IMPROVED TOPICAL DELIVERY OF DRUGS RICHARDSON VICKS INC (US) 1998-07-22 EP claimed
US-5773023-A BLEND OF AQUEOUS CARRIER, ACTIVE MATERIAL AND POLYACRYLAMIDE RICHARDSON-VICKS INC. (US) 1998-06-30 US claimed
EP-0608320-B1 ENHANCED SKIN PENETRATION SYSTEM FOR IMPROVED TOPICAL DELIVERY OF DRUGS RICHARDSON VICKS INC (US) 1998-01-28 EP claimed
EP-0652774-B1 PHARMACEUTICAL COMPOSITION FOR TOPICAL USE CONTAINING A CROSSLINKED CATIONIC POLYMER AND AN ALKOXYLATED ETHER PROCTER & GAMBLE (US) 1997-05-07 EP claimed
US-5614178-A TRANSDERMAL THE PROCTER & GAMBLE COMPANY (US) 1997-03-25 US claimed
EP-0722268-A1 HERBICIDAL AZA BISPHOSPHONIC ACID COMPOSITIONS ZENECA LIMITED (GB) 1996-07-24 EP claimed
EP-0652774-A1 PHARMACEUTICAL COMPOSITION FOR TOPICAL USE CONTAINING A CROSSLINKED CATIONIC POLYMER AND AN ALKOXYLATED ETHER. PROCTER & GAMBLE (US) 1995-05-17 EP claimed
WO-1995010188-A2 HERBICIDAL AZA BISPHOSPHONIC ACID COMPOSITIONS ZENECA LIMITED (GB) 1995-04-20 WO claimed
EP-0608322-A1 ENHANCED SKIN PENETRATION SYSTEM FOR IMPROVED TOPICAL DELIVERY OF DRUGS RICHARDSON-VICKS, INC. (US) 1994-08-03 EP claimed
EP-0608320-A1 ENHANCED SKIN PENETRATION SYSTEM FOR IMPROVED TOPICAL DELIVERY OF DRUGS RICHARDSON-VICKS, INC. (US) 1994-08-03 EP claimed
EP-0274158-B1 Novel heterocycle-substituted diphosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate matabolism NORWICH EATON PHARMA (US) 1994-03-23 EP claimed
WO-1994002176-A1 PHARMACEUTICAL COMPOSITION FOR TOPICAL USE CONTAINING A CROSSLINKED CATIONIC POLYMER AND AN ALKOXYLATED ETHER THE PROCTER & GAMBLE COMPANY (US) 1994-02-03 WO claimed
WO-1993007902-A1 ENHANCED SKIN PENETRATION SYSTEM FOR IMPROVED TOPICAL DELIVERY OF DRUGS RICHARDSON-VICKS, INC. (US) 1993-04-29 WO claimed
WO-1993007903-A1 ENHANCED SKIN PENETRATION SYSTEM FOR IMPROVED TOPICAL DELIVERY OF DRUGS RICHARDSON-VICKS, INC. (US) 1993-04-29 WO claimed
US-5728650-A Herbicidal aza bisphosphonic acids and compositions containing the same ZENECA LIMITED (GB) 1998-03-17 US disclosed
EP-0722268-A1 HERBICIDAL AZA BISPHOSPHONIC ACID COMPOSITIONS ZENECA LIMITED (GB) 1996-07-24 EP disclosed
US-5519013-A Heterocycle-substituted diphosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism THE PROCTER & GAMBLE COMPANY (US) 1996-05-21 US disclosed
WO-1992021355-A1 CALCIUM, TRACE MINERAL, VITAMIN D AND DRUG THERAPY COMBINATIONS THE PROCTER & GAMBLE COMPANY (US) 1992-12-10 WO disclosed
US-5071840-A Certain heterocyclic substituted diphosphonate compounds pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism NORWICH EATON PHARMACEUTICALS, INC. (US) 1991-12-10 US disclosed
EP-0351897-A2 Skin penetration system for salts of amine-functional drugs THE PROCTER & GAMBLE COMPANY (US) 1990-01-24 EP disclosed